DECOMPENSATED CIRRHOSIS
Clinical trials for DECOMPENSATED CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new DECOMPENSATED CIRRHOSIS trials appear
Sign up with your email to follow new studies for DECOMPENSATED CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a protein infusion cut dangerous fluid buildup in liver disease?
Disease control Recruiting nowThis study tests whether giving a higher dose of albumin (a protein) to people with advanced liver cirrhosis and fluid buildup (ascites) can reduce the need for fluid drainage procedures and prevent complications. About 100 adults with hard-to-treat ascites will receive either hi…
Matched conditions: DECOMPENSATED CIRRHOSIS
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Smartwatch and app could keep liver patients out of hospital
Disease control Recruiting nowThis study tests whether a home monitoring system called CirrhoCare can help people with decompensated cirrhosis avoid unplanned hospital visits. Participants use an Apple Watch, iPhone app, and Bluetooth devices to track their health at home. The trial will compare this approach…
Matched conditions: DECOMPENSATED CIRRHOSIS
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control Recruiting nowThis study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the thera…
Matched conditions: DECOMPENSATED CIRRHOSIS
Phase: PHASE1, PHASE2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study investigates hidden heart risk in liver patients
Knowledge-focused Recruiting nowThis study looks at a heart condition called cirrhotic cardiomyopathy that can affect people with advanced liver disease (cirrhosis). Researchers want to learn how common it is, what increases the risk, and whether bile acids in the blood play a role. About 440 adults with decomp…
Matched conditions: DECOMPENSATED CIRRHOSIS
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC